Business
Cohance Lifesciences investing $18 million in NJ Bio,Aruka Bio to sharpen focus on ADC
The investments will aid in deeper integration of NJ Bio’s customer-facing services and focused development of Aruka’s proprietary pipeline through potential partnerships. Both the transactions will be funded through internal accruals.
This story summarizes reporting from The Hindu. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.
Read full story on The Hindu →
India — The Hindu

